IRDG 169

Theme : Is this the end of the road for off-line testing?

Date : 19th June 2002

Location : Pfizer Limited, Sandwich, Kent

Programme

  • Introduction to the applications of PAT (Process Analysis Technology) within Pfizer
    • Steve Hammond, (Pfizer Ltd)
  • Crystallisation Monitoring
    • David Lee, (GlaxoSmithKline)
  • Is a generic solution to reaction monitoring possible in the Pharma industry?
    • Martin Warman, (Pfizer Ltd)
  • Near IR identity testing. Some whys, wheres and hows
    • Steve Holland, (AstraZeneca)
  • Industrial strength near-infrared chemical imaging
    • Neil Lewis, (Spectral Dimensions, MD, USA)
  • Generic solutions in the Pharma industry. Part 2
    • Martin Warman, (Pfizer Ltd.)